Page last updated: 2024-09-04

beta-lactams and Escherichia coli Infections

beta-lactams has been researched along with Escherichia coli Infections in 248 studies

Research

Studies (248)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (2.82)	18.7374
1990's	11 (4.44)	18.2507
2000's	64 (25.81)	29.6817
2010's	149 (60.08)	24.3611
2020's	17 (6.85)	2.80

Authors

Authors	Studies
Ganaie, F; Mitra, S; Shome, BR; Shome, R; Tewari, R; Venugopal, N	1
Andersson, DI; Fatsis-Kavalopoulos, N; Roelofs, L	1
Abendroth, L; Bautsch, W; Häussler, S; Neffe, L; Tomasch, J	1
Kusaksizoglu, A; Nordmann, P; Ortiz de la Rosa, JM; Poirel, L; Sadek, M; Sakaoglu, Z	1
Turumtay, H	1
Acosta, D; Benning, M; Sarangarm, P; Walraven, C	1
Ding, Y; Du, Y; Kang, W; Lai, J; Li, Y; Liu, X; Wang, J; Wang, Y; Xiao, R; Zhang, J; Zou, P	1
Hasani, A; Nahandi, MZ; Nejad, MK; Soofiyani, SR	1
Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB	1
Johnson, JR; Johnston, BD; Thuras, PD	1
Chakraborty, T; Falgenhauer, L; Imirzalioglu, C; Kessler, J; Masseron, A; Nordmann, P; Poirel, L	1
Cavaco, LM; Hammerum, AM; Hansen, F; Hasman, H; Roer, L	1
Cheong, E; Darling, AE; Djordjevic, SP; Fourment, M; Gottlieb, T; Hastak, P; Merlino, J; Myers, GSA; Roy Chowdhury, P	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Antsupova, V; Arpi, M; Boel, JB; Holzknecht, BJ; Jarløv, JO; Knudsen, JD	1
Afra, K; Lee, C; Mina, N; Saad, S	1
Abd El-Aziz, AM; Abdelmegeed, ES; Hassan, R; Khalifa, SM	1
Debarbieux, L; Delattre, R; Dufour, N; Ricard, JD	1
Tamma, PD; Villegas, MV	1
Kiertiburanakul, S; Malaisri, C; Phuphuakrat, A; Santanirand, P; Wibulpolprasert, A	1
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y	1
Coll, P; Espinal, P; Gómez, L; Miró, E; Navarro, F; Plasencia, V; Segura, C	1
Monogue, ML; Nicolau, DP	1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK	1
Boyer, S; Caron, Y; Chheang, R; Kerléguer, A; Puthea, N; Soda, M; Tarantola, A	1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Batzias, GC; Delis, GA; Koutsoviti-Papadopoulou, M; Siarkou, VI; Vingopoulou, EI	1
Cao, Y; Huang, R; Liu, JH; Lv, L; Wang, J; Wen, Q; Yu, P; Zhang, Q; Zhi, C	1
Chen, X; Cui, Y; Li, W; Ni, J; Shang, F; Xue, T; Yu, L; Zhang, M	1
Gupta, S; Mukhopadhyay, C; Pathak, A; Prasad, KN; Rahman, M; Rai, RP; Singh, A; Singh, S	1
Bhat, U; Huilgol, P; Karunasagar, I; Mohan Raj, JR; Vittal, R	1
Ferreira, H; Gonçalves, D; Mota, R; Palmeira, J; Pinto, M	1
Amoroso, AM; D'hooghe, M; Decuyper, L; Deketelaere, S; Gobec, S; Joris, B; Jukič, M; Sauvage, E; Sosič, I; Vanparys, L; Verlaine, O	1
Beucher, G; Cazanave, C; Charlier, C	1
Alejo-Cancho, I; Alvarez-Martinez, MJ; Gonçalves Quiles, M; Guiral, E; Marco, F; Moreno-Morales, J; Muñoz, L; Salvador, P; Vila, J	1
Ghosh, AS; Ghosh, SK; Kumar N, G; Kumar, G; Mallick, S; Pramanick, P	1
Fernando, S; Gejji, V; Jayaraman, A; Karthikeyan, R; Menon, R; Wang, H	1
Barrios-Arnau, L; Di Capua-Sacoto, C; Gomila Sard, B; Ponce-Blasco, P; Rodrigo-Aliaga, M; Sanchez-Llopis, A	1
Dahal, RK; Kirikae, T; Miyoshi-Akiyama, T; Ohara, H; Pokhrel, BM; Sah, MK; Tada, T	1
Babinchak, T; Badal, R; Bouchillon, S; Hackel, M; Hawser, S; Hoban, D; Lob, S	1
Alberola, J; Artero, A; Cano, A; Eiros, JM; Nogueira, JM	1
Chen, Q; Rui, Y; Sun, J; Wang, F; Wang, Q; Wu, K; Yu, S; Zheng, F	1
Bonten, MJ; Cohen Stuart, JW; Dorigo-Zetsma, JW; Frakking, FN; Kluytmans, JA; Leverstein-van Hall, MA; Lutgens, SP; Prins, JM; Rottier, WC; Thijsen, SF; van Hattem, JM; van Hees, BC; Verbon, A; Vlaminckx, BJ	1
Chaudhary, M; Kumar, S; Payasi, A	1
Araque, M; Mendoza, E; Millán, B; Salas, M	1
Chung, C; Desjardins, M; Ellis, C; Melano, RG; Patel, SN; Tijet, N; Toye, B	1
Friese, A; Guerra, B; Käsbohrer, A; Kreienbrock, L; Laube, H; Roesler, U; von Salviati, C	1
Bauer, J; Hölzel, CS; Schwaiger, K	1
Kumar, A; Shahi, SK; Singh, VK	1
Anway, R; Clabots, C; Colpan, A; Johnson, JR; Johnston, B; Kuskowski, MA; Porter, S; Sokurenko, EV; Tchesnokova, V; Thao, L	1
Belas, A; Bellido, M; Cavaco-Silva, P; Couto, N; López-Cerero, L; Pascual, A; Pomba, C; Rodríguez-Baño, J; Serrano, L	1
Daisy, P; Murugan, M; Rajapandiyan, K; Ranjitsingh, AJ; Shanthi, S; Vijayalakshmi, P	1
Evans, NJ; Fick, JC; Maciuca, IE; Timofte, D; Wattret, A; Williams, H; Williams, NJ	1
Lü, X; Zhang, L; Zong, Z	1
Eller, C; Höller, C; Krupa, E; Lehner-Reindl, V; Nickel, S; Pfeifer, Y; Valenza, G	1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C	1
Cornaglia, G; Kocsis, E; Lo Cascio, G; Mazzariol, A; Piccoli, M	1
Bures, J; Hera, A; Koutecka, L; Kucerova, Z; Nechvatalova, K; Nedbalcova, K; Pokludova, L	1
Hidalgo, G; Hidalgo, M; Jugo, MB; Maccallini, GC; Villar, HE; Visser, M	1
Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G	1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T	1
Ben Sallem, R; Ben Slama, K; Boudabous, A; Jouini, A; Klibi, N; Porres-Osante, N; Rojo-Bezares, B; Sáenz, Y; Torres, C	1
Blackmore, T; Losco, G; Studd, R	1
Fernández, J; Fleites, A; Montero, I; Rodicio, MR	1
Alvarado, A; Carrero, G; Fajardo, C; Gómez, F; Jiménez, A	1
Agersø, Y; Hasman, H; Jensen, JD; Pedersen, K	1
John, KR; Kesavan, LM; Kumar, VA; Manoharan, A; Mathai, D; Paul, B; Sugumar, M	1
Absar, MM; Al Hedaithy, MA; Al Subaie, SS; Arshad, MZ; Habib, HA; Manneh, K; Murray, TS; Sayyed, SB; Shakoor, Z; Somily, AM	1
Feng, P; Xie, Y; Yang, P; Zong, Z	1
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N	1
Agassounon-Djikpo Tchibozo, M; Akpovi, CD; Anago, E; Ayi-Fanou, L; Bankole, HS; Hounkpe, WB; Sanni, A	1
Chowers, M; Krashin, E; Lishner, M; Reisfeld, S	1
Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA	1
George, LV; Molnar, GP; Stephens, KJ; Stewart, JT	1
Chen, X; Feng, Y; Liu, Y; Wang, X; Wu, W; Xie, Y; Zhang, X; Zong, Z	1
Eslami, G; Langaee, T; Rafati, M; Rafiei, A; Rezai, MS; Salehifar, E; Shafahi, K	1
Caniça, M; Jones-Dias, D; Manageiro, V	1
Adler, A; Blum, SE; Carmeli, Y; Fallach, N; Hussein, O; Klement, E; Schwaber, MJ; Sturlesi, N; Zilberman-Barzilai, D	1
Samuelsen, Ø; Småbrekke, L; Sundsfjord, A; Zykov, IN	1
Bakour, R; Bonnet, R; Hamidi, M; Messai, Y; Robin, F; Yahiaoui, M	1
Bjørnvad, CR; Bortolaia, V; Espinosa-Gongora, C; Guardabassi, L; Jessen, LR; Langebæk, R; Shah, SQ	1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K	1
Arakawa, Y; Fujita, A; Jin, W; Kimura, K; Mikamo, H; Suematsu, H; Wachino, J; Yamada, K; Yamagishi, Y; Yokoyama, S	1
Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S	1
Bortolaia, V; Damborg, P; Guardabassi, L; Morsing, MK; Petersen, T	1
Barbosa, FC; Pinto, VP; Rocha, FR	1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH	1
Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I	1
Al Atya, AK; Drider, D; Drider-Hadiouche, K; Vachee, A	1
Arce Gil, Z; Flores Clavo, R; Rivera-Jacinto, M; Rodríguez-Ulloa, C; Serquén López, L	1
Brasme, L; De Champs, C; Gharout-Sait, A; Guillard, T; Mairi, A; Touati, A; Yousfi, M	1
Arakawa, Y; Goto, K; Kawamura, K; Nakane, K	1
Hamamoto, K; Hirai, I; Toyosato, T; Ueda, S; Yamamoto, Y	1
Adak, GK; Byrne, L; Charlett, A; Harker, K; Jenkins, C; Launders, N	1
Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V	1
Agyekum, A; Ai, X; Fajardo-Lubián, A; Ginn, AN; Guo, X; Iredell, JR; Partridge, SR; Turnidge, J; Zong, Z	1
Alonso, CA; Bellaaj, R; Ben Said, L; Ben Slama, K; Boudabous, A; Chairat, S; Dziri, R; Jouini, A; Klibi, N; Torres, C	1
Aberkane, S; Bouzinbi, N; Carriere, C; Decré, D; Godreuil, S; Jean-Pierre, H; Kissou, A; Nacro, B; Ouédraogo, AS; Ouédraogo, R; Poda, A; Sanou, S; Van De Perre, P	1
Aracil, B; Bautista, V; Campos, J; Fernández-Romero, S; Lara, N; Ortega, A; Oteo, J; Pérez-Vázquez, M; Sáez, D	1
Dobiasova, H; Dolejska, M	1
Feng, Y; Li, J; Li, S; Sun, H; Xu, W; Xue, G; Yan, C; Zhao, H	1
Nicolau, DP; Sutherland, CA; Verastegui, JE	1
Freitag, C; Hassel, M; Kadlec, K; Michael, GB; Schwarz, S	1
Fujii, S; Fujino, K; Hashimoto, J; Hiyama, Y; Ichihara, K; Masumori, N; Shinagawa, M; Takahashi, S; Uehara, T	1
Boroumandi, S; Ghafoori, SM; Heidari, H; Houri, H; Kazemian, H; Tayebi, Z	1
Ashour, MS; El-Badawy, MF; Maghrabi, IA; Mansy, MS; Shohayeb, MM; Tawakol, WM	1
Arevalo, A; Bernal, JF; Castellanos, LR; Clavijo, V; Donado-Godoy, P; Hordijk, J; León, M; Mevius, DJ; Timmerman, AJ; Wagenaar, JA	1
Bhattacharjee, A; Chakravarty, A; Choudhury, NA; Dhar, D; Ingti, B; Maurya, AP; Paul, D	1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L	1
Fujimura, T; Fukuhara, H; Homma, Y; Horiuchi, T; Kamei, J; Kume, H; Moriya, K; Nakagawa, T; Sato, T; Yagihara, Y	1
Kim, JH; Kim, MJ; Sohn, JW; Yang, KS; Yoon, YK	1
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N	1
Bae, IK; Hong, SG; Jeong, HJ; Jeong, SH; Lee, SH; Lee, YH	1
Chen, Y; Deng, L; Deng, QL; Liu, L; Lu, Q; Shen, XZ; Wang, CQ; Wang, L; Wang, Y; Xu, XW; Yang, YH; Zhang, H	1
Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L	1
Ensor, VM; Evans, JT; Hawkey, PM; Jamal, W; Rotimi, VO	1
Almela, M; Marco, F; Martínez, JA; Mensa, J; Muñoz, A; Ortega, M; Soriano, A	1
Bae, IK; Jeong, SH; Kim, JS; Kwak, HS; Lee, H; Lee, K; Song, W	1
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR	1
Chen, HM; Tsai, PF; Wann, JY; Wu, JJ; Yan, JJ	1
Matull, WR; Morgan, MY; O'Beirne, J; O'Neill, S; Smith, R; Wright, G; Zambreanu, L	1
Badri, M; Donaghy, P; Karisik, E; Livermore, DM; Loughrey, AC; McCalmont, M; O'Leary, MC; Rooney, PJ; Smyth, B; Woodford, N	1
Koike, K; Kumita, W; Moriya, K; Ode, T; Okamura, N; Okugawa, S; Saito, R; Sato, K	1
Muniandy, S; Navaratnam, P; Palasubramaniam, S	1
Bindayna, KM; Botta, GA; Khanfar, HS; Senok, AC	1
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF	1
Blot, S; Memon, JI	1
Calvert, K; Clark, J; Hayden, MK; Lolans, K; Won, S	1
Fjeldsøe-Nielsen, H; Friis-Møller, A; Jørgensen, RL; Nielsen, JB; Schønning, K	1
Aihara, Y; Harada, T; Ito, S; Machida, H; Teranishi, J; Yokota, S	1
Hwang, KP; Shen, YH; Tang, YF	1
Pilla, V; Qi, C; Reed, K; Yu, JH	1
Muir, A; Weinbren, MJ	1
Cantón, R; Coque, TM; del Campo, R; Martín, O; Morosini, MI; Rodríguez-Baños, M; Rodríguez-Domínguez, M; Valverde, A	1
Hao, F; Ma, N; Wang, H; Wei, X; Wen, Z; Xiao, Y; Xue, F; Zhu, Y	1
Akata, F; Celik, AD; Eroglu, C; Kuloglu, F; Torol, S; Vahaboğlu, H; Yulugkural, Z	1
Andre, C; Arpin, C; Coulange, L; De Barbeyrac, B; Dubois, V; M'zali, F; Megraud, F; Quentin, C; Rogues, AM	1
Coll, P; de la Cruz, F; Garcillán-Barcia, MP; Mata, C; Mirelis, B; Miró, E; Navarro, F	1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S; Schechner, V; Schwaber, MJ	1
Ko, WC; Lee, CC; Wu, JJ; Yan, JJ; Yang, FC	1
Dogra, V; Loomba, P; Mishra, B; Taneja, J; Thakur, A	1
Auncharoen, A; Chanawong, A; Kaewkes, W; Lulitanond, A; Pienthaweechai, K; Singtohin, S; Songsri, J; Sribenjalux, P	1
Babu, E; Bäcker, M; Bratu, S; Kelly, P; Landman, D; Quale, J; Shah, N; Urban, C	1
Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA	1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N	1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F	1
Carattoli, A; Fashae, K; Fortini, D; García-Fernández, A; Villa, L	1
Nordmann, P; Poirel, L; Toleman, MA; Walsh, TR	1
Peirano, G; Pitout, JD; van Greune, CH	1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC	1
Castanheira, M; Jones, RN; Mendes, RE; Woosley, LN	1
Buffé, C; Dalla Costa, T; de Araujo, BV; Diniz, A; Palma, EC	1
Chen, XY; Liao, XP; Liu, BT; Liu, YH; Sun, J; Wang, XM; Zhu, HQ	1
Hopkins, KL; Kirchner, M; Teale, C; Wearing, H	1
Cha, SB; Hameed, A; Hasan, F; Hussain, M; Jung, M; Rayamajhi, N; Shah, AA; Yoo, HS	1
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C	1
Bloemberg, GV; Böttger, EC; Giger, J; Hombach, M; Peter-Getzlaff, S; Poledica, M; Polsfuss, S; Zbinden, R	1
Bender, JB; Hedberg, CW; Hedican, EB; Reiter, PL; Smith, KE; Wilker, PR	1
Nordmann, P; Poirel, L; Potron, A; Verdavaine, D	1
Kant, A; Mevius, D; van Essen-Zandbergen, A; Veldman, K	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ	1
López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C	1
Boo, TW; Boyle, F; Cotter, M; Khan, A; O'Connell, B	1
Aibinu, I; Ghebremedhin, B; Koenig, W; Odugbemi, T	1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E	1
Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B	1
Briales, A; de Alba, PD; Martínez-Martínez, L; Pascual, A; Rodríguez-Baño, J; Rodríguez-Martínez, JM; Velasco, C	1
Fong, JJ; Radigan, EA; Rosé, L	1
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC	1
Fischer, J; Friese, A; Guerra, B; Helmuth, R; Rodríguez, I; Roesler, U; Schmoger, S	1
Badal, RE; Bouchillon, SK; Hackel, MA; Hawser, SP; Hoban, DJ; Lascols, CA; Rossi, F; Villegas, MV	1
Tsai, LH; Wu, JJ; Yan, JJ	1
Butaye, P; Goddeeris, BM; Kariuki, S; Kiiru, J	1
Di Conza, J; Ghiglione, B; Gutkind, G; Pallecchi, L; Pino, M; Radice, M; Rossolini, GM; Santella, G; Sennati, S	1
Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O	1
Amyes, SG; Dimude, JU	1
Cherkaoui, A; Nordmann, P; Poirel, L; Potron, A; Renzi, G; Schrenzel, J	1
Eller, C; Pfeifer, Y	1
Carmeli, Y; Chmelnitsky, I; Karfunkel, D; Kotlovsky, T; Navon-Venezia, S	1
Geser, N; Hächler, H; Kotsakis, SD; Lehner, A; Miriagou, V; Stephan, R; Tzouvelekis, LS	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ; Paterson, DL	1
Brito, F; Costa, L; Gonçalves, A; Igrejas, G; Poeta, P; Radhouani, H; Silva, N; Sousa, M	1
Jourdan, J; Lavigne, JP; Merle, C; Sirot, D; Sotto, A; Soussy, CJ	1
Briñas, L; Ruiz-Larrea, F; Sáenz, Y; Torres, C; Zarazaga, M	1
Bou, G; Canle, D; Cartelle, M; Eiros, JM; Guerrero, A; Molina, F; Moure, R; Tomas, M	1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL	1
Baraduc, R; Bonnet, R; Chanal, C; De Champs, C; Recule, C; Sirot, D; Sirot, J	1
Franiczek, R; Grabowski, M; Mowszet, K; Pytrus, T; Sobieszczańska, B	1
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M	1
Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM	1
Bae, IK; Jeong, BC; Jeong, SH; Jung, HI; Kim, SJ; Kwon, SB; Lee, JH; Lee, SH; Song, JS	1
Chryssouli, Z; Galani, I; Giamarellou, H; Katsala, D; Souli, M	1
Cui, WL; Li, WL; Wang, LX; Xu, DX	1
Babalola, C; Banevicius, MA; Maglio, D; Nicolau, DP; Nightingale, CH; Sutherland, C	1
Del Carmen Rodríguez, M; Ramírez-Ronda, CH; Saavedra, S; Vera, DE	1
Aarestrup, FM; Hasman, H; Olesen, I	1
Campillos, P; Cebrián, L; Gonzalo-Jiménez, N; López-Lozano, JM; Rodríguez-Díaz, JC; Royo, G; Yagüe, A	1
Fortineau, N; Lartigue, MF; Nordmann, P	1
Giakkoupi, P; Sestan-Crnek, S; Skrlin, J; Tambic-Andrasevic, A; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S	1
Calbo, E; Garau, J; Gómez, L; Quintana, S; Romaní, V; Vidal, CG; Vila, J; Xercavins, M	1
Caniça, M; Castro, AP; Diogo, J; Louro, D; Mendonça, N	1
Aarestrup, FM; Agersø, Y; Harksen, S; Hasman, H; Jensen, LB; Svensmark, B	1
Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B	1
Cirioni, O; Della Vittoria, A; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C	1
Dahl, KH; Haldorsen, B; Simonsen, GS; Steinbakk, M; Sundsfjord, A; Tofteland, S; Walsh, TR	1
DeRyke, CA; Nicolau, DP	1
Banevicius, MA; DeRyke, CA; Fan, HW; Nicolau, DP	1
Adewoye, L; Ghimire, S; Li, XZ; Mehrotra, M	1
Belhadj, O; Ben-Achour, N; Chouchani, C; M'Charek, A	1
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H	1
Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM	1
Aubert, D; Mazoit, JX; Nordmann, P; Poirel, L; Vimont, S	1
Kechrid, A; Réjiba, S	1
Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD	1
Cueto, Md; Gálvez, J; Muniain, MA; Navarro, MD; Pascual, A; Perea, EJ; Rodríguez-Baño, J; Romero, L	1
Yoshida, A	1
Alos, JI; Cacho, J; Cuadros, J; Gomez-Garces, JL; Orden, B; Tamayo, J	1
Ko, CS; Koo, SH; Kwon, GC; Park, JW; Shin, SY; Sung, JY	1
Apisarnthanarak, A; Dejsirilert, S; Kiratisin, P; Kitphati, R; Mundy, LM; Saifon, P	1
Botto, H; Bourg, G; Combescure, C; Lavigne, JP; Sotto, A	1
Ip, M; Kei, HW; Lau, WC; Lee, N; Marasinghe, T; Wong, KY; You, JH	1
Ariza, J; Calatayud, L; Domínguez, MA; Gudiol, C; Gudiol, F; Peña, C; Pujol, M; Tubau, F	1
Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y	1
Chen, Y; Deng, L; Deng, Q; Ding, H; Liu, L; Lu, Q; Shen, X; Wang, A; Wang, C; Wang, L; Wang, Y; Xu, X; Yang, Y; Zhang, H	1
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN	1
Isono, M; Kobayashi, T; Ueno, K; Umemura, A; Watanabe, K; Yamada, N	1
Goto, S; Muto, Y; Ohashi, Y; Okumura, K; Tsuji, A; Tsuji, H	1
Bailey, TC; Jett, BD; Reichley, R; Ritchie, DJ; Sahm, DF	1
Cheng, AF; French, GL; Ling, TK; Lyon, DJ	1
Hiramatsu, K; Tateda, E; Yokota, T; Yoshida, T	1
Gazouli, M; Miriagou, V; Prinarakis, EE; Tzelepi, E; Tzouvelekis, LS	1
Biedenbach, DJ; Jones, RN; Pfaller, MA; Shen, D; Winokur, PL	1
Bradford, PA; Fingerman, IM; Petersen, PJ; White, DG	1
Chang, SC; Ho, M; Hsueh, PR; Lee, CY; Lin, FM; Lu, PL; Luh, KT; Siu, LK	1
Jarlier, V; Sougakoff, W	1
Girlich, D; Karim, A; Nordmann, P; Spicq, C	1
Jeong, SH; Lee, KJ; Lee, SH	1
King, T; Moss, S; O'Boyle, D; Townsend, K; Trott, DJ; Warren, A; Yates, R	1
Caniça, M; Correia, JD; Féria, C; Ferreira, E; Gonçalves, J	1
Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL	1
Fukada, S; Kojo, H; Mine, Y; Nishida, M; Nonoyama, S	1
Baker, P; Greenwood, D; O'Grady, F	1
Bergström, S; Normark, S	1
Berry, V; Mizen, L; Woodnutt, G	1
Mansa, B; Nir, M; Schumacher, H; Thomsen, VF	1
Carneiro, G; Peixe, ML; Queirós, ML; Rebelo, I; Sousa, JC	1
Bennett, IS; Broom, NJ; Coleman, K; Coulton, S; Edwards, PD; Francois, I; Griffin, DR; Osborne, NF; Woodall, PM	1
Aoki, B; Kojima, K; Kuroki, T; Matsumoto, M; Nehashi, T; Ohi, N	1

Reviews

7 review(s) available for beta-lactams and Escherichia coli Infections

Article	Year
Aptitude of Uropathogenic Escherichia coli in Renal Transplant Recipients: A Comprehensive Review on Characteristic Features, and Production of Extended Spectrum β-Lactamase. Current microbiology, 2023, Oct-21, Volume: 80, Issue:12 Topics: Anti-Bacterial Agents; Aptitude; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Kidney Transplantation; Urinary Tract Infections; Uropathogenic Escherichia coli	2023
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
The Spread of CTX-M-Type Extended-Spectrum β-Lactamases in Brazil: A Systematic Review. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Transfer, Horizontal; Hospitals; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology	2016
Addressing the challenge of extended-spectrum beta-lactamases. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections	2009
beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Veterinary microbiology, 2007, Apr-15, Volume: 121, Issue:3-4 Topics: Animal Diseases; Animals; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Salmonella; Salmonella Infections, Animal	2007
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections	2007
Multi-drug resistant escherichia coli with extended-spectrum beta-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs. Australian veterinary journal, 2001, Volume: 79, Issue:9 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Length of Stay; Male; Microbial Sensitivity Tests	2001

Trials

7 trial(s) available for beta-lactams and Escherichia coli Infections

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:8 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pilot Projects; Pyelonephritis	2017
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections	2017
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections	2003
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:4 Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2006
In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:4 Topics: Adult; Animals; Bacterial Adhesion; beta-Lactam Resistance; beta-Lactams; Caenorhabditis elegans; Capsules; Cell Line; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Female; Humans; Treatment Outcome; Urinary Tract Infections; Vaccinium macrocarpon	2008
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology, 2002, Volume: 60, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections	2002

Other Studies

235 other study(ies) available for beta-lactams and Escherichia coli Infections

Article	Year
Occurrence and characterization of genetic determinants of β-lactam-resistance in Escherichia coli clinical isolates. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 100 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Plasmids	2022
Potential risks of treating bacterial infections with a combination of β-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates. EBioMedicine, 2022, Volume: 78 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactams; Drug Synergism; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests	2022
High plasmidome diversity of extended-spectrum beta-lactam-resistant Escherichia coli isolates collected during one year in one community hospital. Genomics, 2022, Volume: 114, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Hospitals, Community; Humans; Plasmids	2022
NDM-35-Producing ST167 Antimicrobial agents and chemotherapy, 2022, 08-16, Volume: 66, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests	2022
Whole-genome sequencing-based characteristics of Escherichia coli Rize-53 isolate from Turkey. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Tetracyclines; Turkey	2023
Revisiting β-Lactams for Treatment of Urinary Tract Infections: Assessing Clinical Outcomes of Twice-Daily Cephalexin for Empiric Treatment of Uncomplicated Urinary Tract Infections. Journal of clinical pharmacology, 2023, Volume: 63, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Cephalexin; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Retrospective Studies; Urinary Tract Infections	2023
Antibiotic susceptibility of Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; China; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Multilocus Sequence Typing	2023
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins	2020
Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status. Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; beta-Lactams; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Genotype; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Prevalence; United States; Veterans	2020
Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection. Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Humans; Immunoassay; Microbial Sensitivity Tests; Switzerland	2020
Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Recurrence; Sepsis; Virulence; Virulence Factors	2020
Emerging microbes & infections, 2020, Volume: 9, Issue:1 Topics: Anti-Bacterial Agents; Australia; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids	2020
Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus. The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1 Topics: Amdinocillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract; Urinary Tract Infections	2021
Oral beta-lactam step down in bacteremic E. coli urinary tract infections. BMC infectious diseases, 2020, Oct-21, Volume: 20, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood Culture; Clostridioides difficile; Clostridium Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2020
β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae. PloS one, 2021, Volume: 16, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Porins	2021
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Cell Survival; Coliphages; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Phage Therapy; Spheroplasts	2017
Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Propensity Score; Urinary Tract Infections	2017
First Description of bla Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pakistan; Plasmids; Spain; Travel	2018
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli	2017
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli. Infectious diseases (London, England), 2018, Volume: 50, Issue:3 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome	2018
Beta-lactam resistance among Enterobacteriaceae in Cambodia: The four-year itch. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 66 Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cambodia; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies	2018
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
Pharmacodynamic interactions of amikacin with selected β-lactams and fluoroquinolones against canine Escherichia coli isolates. Research in veterinary science, 2018, Volume: 117 Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests	2018
Detection of Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3 Topics: Animals; Anti-Bacterial Agents; Aquaculture; beta-Lactams; Carps; China; Chromosomes, Bacterial; Colistin; Drug Resistance, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fish Diseases; Fluoroquinolones; Gene Expression; Microbial Sensitivity Tests; Plasmids	2018
Imidazole decreases the ampicillin resistance of an Escherichia coli strain isolated from a cow with mastitis by inhibiting the function of autoinducer 2. Journal of dairy science, 2018, Volume: 101, Issue:4 Topics: Ampicillin Resistance; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Homoserine; Imidazoles; Lactones; Mastitis, Bovine	2018
Novel variant NDM-11 and other NDM-1 variants in multidrug-resistant Escherichia coli from South India. Journal of global antimicrobial resistance, 2018, Volume: 14 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Snake Bites; Wound Infection	2018
T4-like Escherichia coli phages from the environment carry bla Letters in applied microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Bacteriophage T4; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Humans; India; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Soil Microbiology; Water Microbiology	2018
Intestinal microbiota as a reservoir of extended-spectrum β-lactamase-producing Escherichia coli: An exploratory study in healthy university students. Journal of global antimicrobial resistance, 2018, Volume: 14 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Portugal; Students; Universities; Young Adult	2018
In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria. Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Oct-12, Volume: 24, Issue:57 Topics: Amination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Computer Simulation; Computer-Aided Design; Drug Design; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Molecular Docking Simulation; Penicillin-Binding Proteins	2018
[Diagnosis and management of intra-uterine infection: CNGOF Preterm Premature Rupture of Membranes Guidelines]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Fever; France; Humans; Infections; Pregnancy; Pregnancy Complications, Infectious; Streptococcal Infections; Streptococcus agalactiae; Uterine Diseases	2018
Emergence of Resistance to Quinolones and β-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Quinolones	2019
Bio-surfactin stabilised silver nanoparticles exert inhibitory effect over New-Delhi metallo-beta-lactamases (NDMs) and the cells harbouring NDMs. FEMS microbiology letters, 2019, 05-01, Volume: 366, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biofilms; Cephalosporins; Escherichia coli; Escherichia coli Infections; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Surface-Active Agents	2019
A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4. Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Boronic Acids; Drug Resistance, Multiple, Bacterial; Enterohemorrhagic Escherichia coli; Escherichia coli Infections; Escherichia coli O104; Humans	2019
[Extended spectrum beta-lactamase producing Escherichia coli in a tertiary hospital. Is there an increase of resistances to beta lactams?] Archivos espanoles de urologia, 2019, Volume: 72, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Retrospective Studies; Tertiary Care Centers; Urinary Tract Infections	2019
NDM-8 metallo-β-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nepal; RNA, Ribosomal, 16S	2013
Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Canada; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Quinolones; United States	2013
Pyelonephritis in pregnancy. How adequate is empirical treatment? Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Comorbidity; Escherichia coli Infections; Female; Fosfomycin; Hospitals, University; Humans; Inappropriate Prescribing; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Recurrence; Retrospective Studies; Spain; Treatment Outcome; Young Adult	2013
Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years. Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Integrases; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multigene Family; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA	2013
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Comorbidity; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome	2013
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams. The Journal of antibiotics, 2013, Volume: 66, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Drug Resistance, Bacterial; Edetic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Sulbactam	2013
CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America. Journal of infection in developing countries, 2013, May-13, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Uropathogenic Escherichia coli	2013
OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Ontario; Plasmids; Young Adult	2013
Longitudinal monitoring of extended-spectrum-beta-lactamase/AmpC-producing Escherichia coli at German broiler chicken fattening farms. Applied and environmental microbiology, 2013, Volume: 79, Issue:16 Topics: Animal Husbandry; Animals; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Germany; Longitudinal Studies; Polymerase Chain Reaction; Poultry Diseases; Prevalence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2013
Selection and persistence of antimicrobial-resistant Escherichia coli including extended-spectrum β-lactamase producers in different poultry flocks on one chicken farm. Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Chickens; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Plasmids; Poultry Diseases; Protein Isoforms; Spectinomycin; Trimethoprim, Sulfamethoxazole Drug Combination	2013
Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam. PloS one, 2013, Volume: 8, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clindamycin; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Multiplex Polymerase Chain Reaction; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Structural Homology, Protein; Structure-Activity Relationship	2013
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Genotype; Humans; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Prevalence; United States; Veterans; Virulence Factors	2013
Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:1 Topics: Animals; beta-Lactamases; beta-Lactams; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Europe; Fluoroquinolones; Genetic Variation; Genotype; Humans; Molecular Typing; Multilocus Sequence Typing; Pets	2014
Prevalence of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli among isolates from community-acquired infections and in silico structural modeling of an ESBL protein. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:2 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Computer Simulation; Escherichia coli; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Prevalence; Sequence Alignment	2014
Detection and molecular characterization of Escherichia coli CTX-M-15 and Klebsiella pneumoniae SHV-12 β-lactamases from bovine mastitis isolates in the United Kingdom. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Animals; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cattle; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Plasmids; United Kingdom	2014
The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China. Annals of clinical microbiology and antimicrobials, 2013, Nov-27, Volume: 12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Communicable Diseases, Emerging; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans	2013
Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asymptomatic Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Feces; Female; Gene Expression; Germany; Humans; Infant; Infant, Newborn; Intestines; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids	2014
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index	2014
KPC-3 carbapenemase harbored in FIIk plasmid from Klebsiella pneumoniae ST512 and Escherichia coli ST43 in the same patient. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:5 Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Bile; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Plasmids; Tigecycline	2014
Resistance to selected beta-lactam antibiotics. Veterinary microbiology, 2014, Jul-16, Volume: 171, Issue:3-4 Topics: Actinobacillus pleuropneumoniae; Animals; beta-Lactamase Inhibitors; beta-Lactams; Cattle; Cattle Diseases; Czech Republic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Mannheimia haemolytica; Microbial Sensitivity Tests; Pasteurella multocida; Pasteurellaceae Infections; Prevalence; Swine; Swine Diseases	2014
[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Thienamycins	2014
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization. Urology, 2014, Volume: 83, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional	2014
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids	2014
IncI1 plasmids carrying bla(CTX-M-1) or bla(CMY-2) genes in Escherichia coli from healthy humans and animals in Tunisia. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Cats; Chickens; Conjugation, Genetic; Dogs; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Meat; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pets; Plasmids; Tunisia	2014
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate. BJU international, 2014, Volume: 113 Suppl 2 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional	2014
Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012. Journal of clinical microbiology, 2014, Volume: 52, Issue:9 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Genotype; Hospitals; Humans; Imipenem; Male; Middle Aged; Plasmids; Spain	2014
[Risk factors associated with the isolation of extended spectrum betalactamases producing Escherichia coli or Klebsiella pneumoniae in a tertiary care hospital in Colombia]. Biomedica : revista del Instituto Nacional de Salud, 2014, Volume: 34 Suppl 1 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Colombia; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Tertiary Care Centers	2014
Spread of extended spectrum cephalosporinase-producing Escherichia coli clones and plasmids from parent animals to broilers and to broiler meat in a production without use of cephalosporins. Foodborne pathogens and disease, 2014, Volume: 11, Issue:9 Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cephalosporinase; Cephalosporins; Chickens; Denmark; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry; Poultry Diseases	2014
Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:1 Topics: Adult; Anti-Bacterial Agents; Asymptomatic Diseases; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Clone Cells; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; India; Prevalence; Rural Population	2015
ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. Journal of infection in developing countries, 2014, Sep-12, Volume: 8, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Saudi Arabia; Tertiary Care Centers; Young Adult	2014
blaNDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Aged; Anti-Bacterial Agents; Asian People; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Genotype; Humans; Male; Plasmids; Sequence Analysis, DNA	2014
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing. BMJ case reports, 2014, Oct-19, Volume: 2014 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin	2014
Antibiotic resistance and genotype of beta-lactamase producing Escherichia coli in nosocomial infections in Cotonou, Benin. Annals of clinical microbiology and antimicrobials, 2015, Jan-17, Volume: 14 Topics: Anti-Bacterial Agents; Benin; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests	2015
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy. The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:12 Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta-Lactams; Candida albicans; Ertapenem; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Fluconazole; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Cirrhosis; Middle Aged; Paracentesis; Shock, Septic	2014
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria. Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds	2015
A critical interaction between ertapenem and valproic acid. Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:3 Topics: Aged, 80 and over; Anti-Bacterial Agents; Antimanic Agents; beta-Lactams; Bipolar Disorder; Drug Interactions; Ertapenem; Escherichia coli Infections; Humans; Male; Valproic Acid	2015
First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA	2015
Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran. BioMed research international, 2015, Volume: 2015 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Male; Urinary Tract Infections	2015
Influence of agricultural practice on mobile bla genes: IncI1-bearing CTX-M, SHV, CMY and TEM in Escherichia coli from intensive farming soils. Environmental microbiology, 2016, Volume: 18, Issue:1 Topics: Agriculture; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids; Soil; Soil Microbiology	2016
Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013. Journal of clinical microbiology, 2015, Volume: 53, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cattle; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction	2015
The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011. Infectious diseases (London, England), 2016, Volume: 48, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Norway; Polymerase Chain Reaction; Sequence Analysis, DNA	2016
Antibiotic Resistance, Virulence, and Genetic Background of Community-Acquired Uropathogenic Escherichia coli from Algeria. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:5 Topics: Adult; Aged; Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Gene Expression; Genotype; Humans; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mutation; Phylogeny; Polymerase Chain Reaction; Sulfonamides; Trimethoprim; Uropathogenic Escherichia coli; Virulence	2015
Quantitative assessment of faecal shedding of β-lactam-resistant Escherichia coli and enterococci in dogs. Veterinary microbiology, 2015, Dec-31, Volume: 181, Issue:3-4 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Shedding; beta-Lactams; Cefotaxime; Denmark; Dogs; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Prevalence	2015
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE. The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult	2015
Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak. PloS one, 2015, Volume: 10, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Tazobactam	2015
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports. Clinical nephrology, 2015, Volume: 84, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections	2015
CTX-M-1 and CTX-M-15-producing Escherichia coli in dog faeces from public gardens. Acta veterinaria Scandinavica, 2015, Nov-25, Volume: 57 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Denmark; Dog Diseases; Dogs; Escherichia coli; Escherichia coli Infections; Feces; Microbial Sensitivity Tests	2015
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine	2016
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis. Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure	2016
Potentialization of β-lactams with colistin: in case of extended spectrum β-lactamase producing Escherichia coli strains isolated from children with urinary infections. Research in microbiology, 2016, Volume: 167, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Colistin; DNA, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; France; Hospitals; Humans; Microbial Sensitivity Tests; Microbial Viability; Molecular Typing; Plasmids; Random Amplified Polymorphic DNA Technique; Urinary Tract Infections	2016
[TEM and CTX-M extended-spectrum beta-lactamase in Klebsiella spp and Escherichia coli isolates from inanimate surfaces of hospital environments]. Revista peruana de medicina experimental y salud publica, 2015, Volume: 32, Issue:4 Topics: beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests	2015
Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:4 Topics: Algeria; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cat Diseases; Cats; Dog Diseases; Dogs; Escherichia coli; Escherichia coli Infections; Feces; Gene Expression; Microbial Sensitivity Tests; Pets; Phylogeny; Plasmids	2016
Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling. Applied and environmental microbiology, 2016, Jan-08, Volume: 82, Issue:6 Topics: Anti-Bacterial Agents; Asian People; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carrier State; Conjugation, Genetic; Disk Diffusion Antimicrobial Tests; Escherichia coli; Escherichia coli Infections; Feces; Food Handling; Gene Transfer, Horizontal; Genotyping Techniques; Healthy Volunteers; Humans; Japan; Plasmids; Serotyping	2016
High Prevalence of Chromosomal blaCTX-M-14 in Escherichia coli Isolates Possessing blaCTX-M-14. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chromosome Mapping; Chromosomes, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Dosage; Gene Expression; Homes for the Aged; Humans; Japan; Mutagenesis, Insertional; Nursing Homes; Plasmids; Sequence Analysis, DNA	2016
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012. BMJ open, 2016, Jan-29, Volume: 6, Issue:1 Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Disease Progression; England; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Incidence; Infant; Male; Middle Aged; Population Surveillance; Retrospective Studies; Risk Factors; Severity of Illness Index; Shiga-Toxigenic Escherichia coli; Young Adult	2016
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report. Medicine, 2016, Volume: 95, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins	2016
Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae. Journal of clinical microbiology, 2016, Volume: 54, Issue:5 Topics: Australia; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Phenotype	2016
Detection of CTX-M-15-Producing Escherichia coli Isolates of Lineages ST131-B2 and ST167-A in Environmental Samples of a Tunisian Hospital. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Fomites; Gene Expression; Hospitals; Humans; Integrons; Male; Microbial Sensitivity Tests; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Skin; Tunisia; Virulence Factors	2016
Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:1 Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Burkina Faso; Case-Control Studies; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Gene Expression; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Multiplex Polymerase Chain Reaction; Phylogeny	2017
Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genetic Variation; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction; Prevalence; Spain	2016
Prevalence and diversity of IncX plasmids carrying fluoroquinolone and β-lactam resistance genes in Escherichia coli originating from diverse sources and geographical areas. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:8 Topics: Animals; Animals, Wild; beta-Lactams; Cluster Analysis; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gene Transfer, Horizontal; Genes, Bacterial; Genetic Variation; Genotype; Global Health; Humans; Molecular Typing; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transformation, Bacterial	2016
High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; China; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Public Health Surveillance; Quinolones; Sequence Analysis, DNA	2017
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates. Annals of clinical microbiology and antimicrobials, 2016, Jun-17, Volume: 15, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2016
Detection of plasmid-borne extended-spectrum β-lactamase (ESBL) genes in Escherichia coli isolates from bovine mastitis. Veterinary microbiology, 2017, Volume: 200 Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cattle; Escherichia coli; Escherichia coli Infections; Female; Germany; Integrons; Mastitis, Bovine; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Replicon	2017
The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:5 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult	2017
Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections. Le infezioni in medicina, 2016, 12-01, Volume: 24, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Inpatients; Iran; Microbial Sensitivity Tests; Outpatients; Prevalence; Quinolones; Urinary Tract Infections	2016
Iodometric and Molecular Detection of ESBL Production Among Clinical Isolates of E. coli Fingerprinted by ERIC-PCR: The First Egyptian Report Declares the Emergence of E. coli O25b-ST131clone Harboring bla Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Egypt; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Polymerase Chain Reaction; Young Adult	2017
High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain. PloS one, 2017, Volume: 12, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chickens; Colombia; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Genetic Heterogeneity; Humans; Phylogeny; Plasmids; Poultry; Poultry Diseases	2017
Occurrence of bla Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:4 Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; India; Plasmids	2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States	2017
Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy. International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; beta-Lactams; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Fluoroquinolones; Humans; Image-Guided Biopsy; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Prostate; Prostatic Neoplasms; Rectum; Risk Factors; Ultrasonography, Interventional	2017
Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli. International journal of antimicrobial agents, 2017, Volume: 49, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Republic of Korea; Retrospective Studies; Survival Analysis; Treatment Failure; Young Adult	2017
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation	2008
A novel bla(CTX-M-14) gene-harboring complex class 1 integron with an In4-like backbone structure from a clinical isolate of Escherichia coli. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; Humans; Integrons; Korea; Polymerase Chain Reaction; Sequence Analysis, DNA	2008
[Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China]. Zhonghua yi xue za zhi, 2008, May-27, Volume: 88, Issue:20 Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Prevalence	2008
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections	2008
Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. International journal of antimicrobial agents, 2009, Volume: 33, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kuwait	2009
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Shock	2009
CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction	2009
Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sensitivity and Specificity	2009
Recurrent bacteremia due to retained embolized glue following variceal obliteration. Endoscopy, 2009, Volume: 41 Suppl 2 Topics: Adult; Bacteremia; beta-Lactams; Embolism; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Ertapenem; Escherichia coli Infections; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Recurrence; Risk Assessment; Severity of Illness Index; Tissue Adhesives; Tomography, X-Ray Computed; Treatment Outcome	2009
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Northern Ireland; Nursing Homes; Prevalence	2009
Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan. International journal of antimicrobial agents, 2009, Volume: 34, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Integrons; Japan; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Plasmids; Quinolones; Sequence Analysis, DNA	2009
Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Western; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Porins; Sequence Analysis, DNA	2009
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. Journal of infection in developing countries, 2009, May-01, Volume: 3, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult	2009
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections	2010
Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Saudi medical journal, 2009, Volume: 30, Issue:10 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors	2009
Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. Journal of clinical microbiology, 2010, Volume: 48, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier State; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Microbial Sensitivity Tests; Rectum; Sensitivity and Specificity	2010
Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Denmark; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoelectric Point; Phenotype; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA	2010
Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Pyelonephritis; Recurrence; Urinary Tract Infections; Vesico-Ureteral Reflux	2010
Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Taiwan	2009
Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:1 Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Ertapenem; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Nitrofurantoin; Prevalence; Urinary Tract Infections; Urine; Uropathogenic Escherichia coli	2010
New Delhi metallo-beta-lactamase: a cautionary tale. The Journal of hospital infection, 2010, Volume: 75, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Microbial Sensitivity Tests	2010
Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain. Journal of clinical microbiology, 2010, Volume: 48, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sequence Analysis, DNA; Spain	2010
Intervention study of the association of antibiotic utilization measures with control of extended-spectrum beta-lactamase (ESBL)-producing bacteria. Microbes and infection, 2010, Volume: 12, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum	2010
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Hospitals, University; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Turkey; Urinary Tract Infections	2010
CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7 Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; France; Genotype; Hospitals, Maternity; Hospitals, University; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Microbial Sensitivity Tests; Plasmids; Pregnancy	2010
In vivo transmission of a plasmid coharbouring bla and qnrB genes between Escherichia coli and Serratia marcescens. FEMS microbiology letters, 2010, Jul-01, Volume: 308, Issue:1 Topics: Aged; beta-Lactamases; beta-Lactams; Blotting, Southern; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Humans; Plasmids; Polymerase Chain Reaction; Quinolones; Serratia Infections; Serratia marcescens	2010
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. Emerging infectious diseases, 2010, Volume: 16, Issue:6 Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Escherichia coli; Escherichia coli Infections; Gastrointestinal Tract; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Plasmids; Vancomycin	2010
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Porins; Taiwan	2010
Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. Journal of infection in developing countries, 2010, Sep-03, Volume: 4, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tetracycline	2010
CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagnostic microbiology and infectious disease, 2010, Volume: 68, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Thailand	2010
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. Journal of clinical microbiology, 2010, Volume: 48, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Connecticut; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; New York City; Ribotyping	2010
[Evolution of Escherichia coli resistance in community acquired peritonitis]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:4 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies	2011
New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine	2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins	2011
Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carrier State; Chickens; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Typing; Multilocus Sequence Typing; Nigeria; Plasmids; Polymerase Chain Reaction; Quinolones; Swine	2011
Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Communicable Diseases, Emerging; Disease Transmission, Infectious; Escherichia coli; Escherichia coli Infections; Humans; India; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Pakistan; Pandemics; Sweden; United Kingdom	2011
Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagnostic microbiology and infectious disease, 2011, Volume: 69, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cohort Studies; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals, Community; Humans; Microbial Sensitivity Tests; Phylogeny; South Africa	2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome	2011
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09). The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6 Topics: Americas; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Europe; Humans; Incidence; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests	2011
PK-PD modeling of β-lactam antibiotics: in vitro or in vivo models? The Journal of antibiotics, 2011, Volume: 64, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Immunocompromised Host; Male; Models, Biological; Piperacillin; Rats; Rats, Wistar	2011
Plasmid-mediated quinolone resistance determinants oqxAB and aac(6')-Ib-cr and extended-spectrum β-lactamase gene blaCTX-M-24 co-located on the same plasmid in one Escherichia coli strain from China. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:7 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chickens; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Agar Gel; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Plasmids; Poultry Diseases; Quinolones	2011
Characterization of plasmids encoding cefotaximases group 1 enzymes in Escherichia coli recovered from cattle in England and Wales. Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:3 Topics: Animals; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cattle; Drug Resistance, Bacterial; England; Escherichia coli; Escherichia coli Infections; Plasmids; Polymerase Chain Reaction; Wales	2011
Prevalence of class A and AmpC β-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Japanese journal of infectious diseases, 2011, Volume: 64, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Pakistan; Plasmids; Polymerase Chain Reaction; Prevalence	2011
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests	2012
Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. Journal of clinical microbiology, 2011, Volume: 49, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA Mutational Analysis; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic	2011
Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. The Pediatric infectious disease journal, 2012, Volume: 31, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Child; Child, Preschool; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Infant, Newborn; Male; Minnesota; Risk Factors; Severity of Illness Index; Young Adult	2012
Importation of KPC-2-producing Escherichia coli from India. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction	2012
Characterization of qnr-positive Escherichia coli isolates from food-producing animals in the Netherlands. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1 Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Netherlands; Quinolones	2012
Trending eight years of in vitro activity of ertapenem and comparators against Escherichia coli from intra-abdominal infections in North America--SMART 2002-2009. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Abdominal Cavity; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; North America; Population Surveillance	2011
First detection of blaIMI-2 gene in a clinical Escherichia coli strain. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA	2012
Dissemination of extended-spectrum β-lactamase-producing Escherichia coli at home: a potential occupational hazard for healthcare workers? The Journal of hospital infection, 2012, Volume: 80, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Humans; Ireland; Male; Microbial Sensitivity Tests; Middle Aged; Physicians; Spouses	2012
Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Nigeria; Plasmids; Polymerase Chain Reaction; Quinolones	2012
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections	2012
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome	2012
Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. International journal of antimicrobial agents, 2012, Volume: 39, Issue:5 Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child, Preschool; Conjugation, Genetic; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Quinolones; Spain	2012
Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged	2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult	2012
Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7 Topics: Animals; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Order; Integrons; Longitudinal Studies; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Swine; Swine Diseases	2012
Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009). Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Intraabdominal Infections; Latin America; Microbial Sensitivity Tests	2012
Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan. International journal of antimicrobial agents, 2012, Volume: 40, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Taiwan	2012
Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period. BMC microbiology, 2012, Jul-28, Volume: 12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Kenya; Microbial Sensitivity Tests; Phenotype; Prevalence	2012
Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genetic Heterogeneity; Humans; Klebsiella Infections; Klebsiella pneumoniae	2012
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea]. Medecine et maladies infectieuses, 2012, Volume: 42, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors	2012
Molecular diversity associated with the dissemination of CTX-M-15 beta-lactamase gene in blood culture isolates of Escherichia coli from Edinburgh. Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:1 Topics: Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Scotland	2013
Emergence of OXA-48-producing Enterobacteriaceae in Switzerland. International journal of antimicrobial agents, 2012, Volume: 40, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Switzerland	2012
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2012, Volume: 55, Issue:11-12 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping	2012
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Polymerase Chain Reaction; Prevalence; Retrospective Studies	2013
Characterisation of CTX-M-117, a Pro174Gln variant of CTX-M-15 extended-spectrum β-lactamase, from a bovine Escherichia coli isolate. International journal of antimicrobial agents, 2013, Volume: 41, Issue:1 Topics: Animals; beta-Lactamases; beta-Lactams; Cattle; Cattle Diseases; Escherichia coli; Escherichia coli Infections; Kinetics; Microbial Sensitivity Tests; Mutation, Missense; Switzerland	2013
Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. International journal of antimicrobial agents, 2013, Volume: 41, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Global Health; Humans; Intraabdominal Infections; Microbial Sensitivity Tests	2013
Genetic characterisation of extended-spectrum β-lactamases in Escherichia coli isolated from retail chicken products including CTX-M-9 containing isolates: a food safety risk factor. British poultry science, 2012, Volume: 53, Issue:6 Topics: Animals; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chickens; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Meat; Polymerase Chain Reaction; Portugal; Poultry Diseases; Risk Factors; Sequence Analysis, DNA	2012
[Enzymatic resistance of Escherichia coli to beta-lactams and clinical prevalence]. Pathologie-biologie, 2002, Volume: 50, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans	2002
Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10 Topics: Ampicillin; Animals; Animals, Domestic; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cattle; Chickens; Dogs; Escherichia coli; Escherichia coli Infections; Feces; Humans; Meat Products; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Swine	2002
Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. Journal of clinical microbiology, 2002, Volume: 40, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cloning, Molecular; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Isoelectric Point; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Spain; Transcription Factors	2002
Effect of D240G substitution in a novel ESBL CTX-M-27. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction	2003
Occurrence of extended-spectrum beta-lactamases among Escherichia coli isolates from hospitalized and healthy children. Folia microbiologica, 2003, Volume: 48, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Diarrhea; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Intestinal Mucosa; Microbial Sensitivity Tests	2003
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections	2004
Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition. FEMS microbiology letters, 2004, May-01, Volume: 234, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Escherichia coli; Escherichia coli Infections; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam	2004
Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Letters in applied microbiology, 2004, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction	2004
First identification of an Escherichia coli clinical isolate producing both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase IBC-1. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests	2004
[Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections	2004
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh model. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Thigh	2005
Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center. Puerto Rico health sciences journal, 2004, Volume: 23, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Hospitals, Veterans; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Puerto Rico	2004
Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microbial drug resistance (Larchmont, N.Y.), 2004,Winter, Volume: 10, Issue:4 Topics: Ampicillin; Animals; Animals, Domestic; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cattle; Chickens; Escherichia coli; Escherichia coli Infections; Meat Products; Microbial Sensitivity Tests; Prevalence; Salmonella; Salmonella Infections; Swine	2004
[Expanded-spectrum beta-lactamase-producing strains of E. coli: origin, characteristics and incidence in Southern Alicante (Spain) in the period 1999-2003]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals, General; Hospitals, University; Humans; Incidence; Inpatients; Outpatients; Spain	2005
Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:7 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter freundii; Enterobacter aerogenes; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Hospitals, University; Humans; Microbial Sensitivity Tests; Paris; Proteus mirabilis	2005
Transferable DHA-1 cephalosporinase in Escherichia coli. International journal of antimicrobial agents, 2006, Volume: 27, Issue:1 Topics: Bacterial Proteins; beta-Lactams; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Conjugation, Genetic; Croatia; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction	2006
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Urinary Tract Infections	2006
CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Portugal	2006
First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Denmark; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Food Microbiology; Plasmids; Swine; Swine Diseases	2006
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock. Shock (Augusta, Ga.), 2006, Volume: 26, Issue:2 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Cecum; Disease Models, Animal; Drug Synergism; Endotoxins; Enterococcus faecalis; Ertapenem; Escherichia coli; Escherichia coli Infections; Interleukin-6; Ligation; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Rats, Wistar; Shock, Septic; Tumor Necrosis Factor-alpha	2006
Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Journal of clinical microbiology, 2007, Volume: 45, Issue:1 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norway; Phenotype	2007
Is all free time above the minimum inhibitory concentration the same: implications for beta-lactam in vivo modelling. International journal of antimicrobial agents, 2007, Volume: 29, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Models, Biological	2007
Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; beta-Lactamases; beta-Lactams; Disease Models, Animal; Ertapenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Thienamycins	2007
Cloning and sequencing of the class A beta-lactamase gene (blaTEM-15) located on a chromosomal Tn801 transposon. Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:4 Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cloning, Molecular; DNA Transposable Elements; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; Infant; Isoelectric Point; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA	2007
Ertapenem resistance of Escherichia coli. Emerging infectious diseases, 2007, Volume: 13, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin	2007
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms. Annals of clinical microbiology and antimicrobials, 2007, Jun-06, Volume: 6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel	2007
Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporinase; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Peritonitis; Plasmids	2007
Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalothin; Child; Escherichia coli; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Penicillins; Tunisia	2007
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli. Journal of medical microbiology, 2007, Volume: 56, Issue:Pt 11 Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis	2007
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Risk Factors; Spain	2008
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:3 Topics: Adult; Anti-Bacterial Agents; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Spain; Urine	2007
[Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon]. The Korean journal of laboratory medicine, 2007, Volume: 27, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea	2007
Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand . Infection control and hospital epidemiology, 2008, Volume: 29, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Thailand	2008
Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli? The Journal of hospital infection, 2008, Volume: 68, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2008
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. The Journal of hospital infection, 2008, Volume: 68, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Case-Control Studies; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Spain; Treatment Outcome; Urinary Tract Infections	2008
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. International journal of antimicrobial agents, 2008, Volume: 31, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey	2008
The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid	2008
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus	1981
[Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)]. The Japanese journal of antibiotics, 1981, Volume: 34, Issue:6 Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; beta-Lactams; Drug Stability; Escherichia coli Infections; Mice; Penicillin G; Penicillin Resistance; Sulbenicillin	1981
Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Chemotherapy, 1982, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Kinetics; Microbial Sensitivity Tests	1982
In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests	1995
In-vitro antimicrobial susceptibility and beta-lactamases of ampicillin-resistant Escherichia coli in Hong Kong. The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:1 Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Isoelectric Focusing; Isoenzymes; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Hybridization	1994
[In vitro antibacterial activity of a new parenteral penem, sulopenem]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Carrier Proteins; Cells, Cultured; Escherichia coli Infections; Hexosyltransferases; Imipenem; Lactams; Macrophages; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	1996
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans	1997
Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases. Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Deoxyribonuclease EcoRI; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Phenotype; Restriction Mapping	1999
Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5 Topics: Animals; beta-Lactamases; beta-Lactams; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Virulence	1999
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. Journal of clinical microbiology, 1999, Volume: 37, Issue:12 Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Conjugation, Genetic; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Oncology Service, Hospital; Pediatrics; Plasmids; Polymerase Chain Reaction	1999
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. The Journal of antimicrobial chemotherapy, 2000, Volume: 46 Suppl 1 Topics: Amdinocillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests	2000
Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2000, Volume: 19, Issue:11 Topics: beta-Lactams; Cephalosporinase; Escherichia coli; Escherichia coli Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Plasmids; Proteus Infections; Proteus mirabilis	2000
Evolution of TEM beta--lactamase genes identified by PCR with newly designed primers in Korean clinical isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:2 Topics: beta-Lactamases; beta-Lactams; DNA Primers; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Evolution, Molecular; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Korea; Polymerase Chain Reaction	2001
Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:1 Topics: Animals; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Microbial Sensitivity Tests; Portugal; Urinary Tract Infections	2002
Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation. The Journal of antibiotics, 1977, Volume: 30, Issue:11 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbenicillin; Cefazolin; Escherichia coli Infections; Kidney; Liver; Male; Mice; Penicillin Resistance; Proteus Infections; Pseudomonas Infections; Serratia marcescens	1977
An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor. The Journal of antimicrobial chemotherapy, 1979, Volume: 5, Issue:5 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cystitis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; Models, Biological; Nephelometry and Turbidimetry; Penicillin Resistance	1979
Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase. Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalothin; Chromosomes, Bacterial; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans	1979
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections	1992
Screening method for beta-lactamase substrate profiles. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1992, Volume: 100, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Methods; Pseudomonas; Reproducibility of Results; Substrate Specificity	1992
Characterization of beta-lactamases encoded by pathogenic strains of Escherichia coli from Portugal. The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Portugal	1991
6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. IV. Kidney stability, serum binding and additional biological evaluation of racemic derivatives. The Journal of antibiotics, 1991, Volume: 44, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Blood Proteins; Drug Stability; Escherichia coli Infections; Humans; Kidney; Magnetic Resonance Spectroscopy; Mice; Molecular Conformation; Protein Binding; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet	1991
Semisynthetic beta-lactam antibiotics. III. Effect on antibacterial activity and comt-susceptibility of chlorine-introduction into the catechol nucleus of 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido]-2- phenylacetamido]penicillanic aci The Journal of antibiotics, 1987, Volume: 40, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Catechol O-Methyltransferase Inhibitors; Escherichia coli Infections; Indicators and Reagents; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Structure-Activity Relationship	1987